Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Fibrosis 2Stomatitis 1Small Cell Lung Carcinoma 1Osteoradionecrosis 1Lymphedema 1Lung Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1

Interventions

Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Blood Specimen Collection 4Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1navitoclax 1maltodextrin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1Viusid 1Vitamin E 1Vitamin D 1Tenofovir 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Fibrosis × Tocopherols × Clear all
NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

M.D. Anderson Cancer Center

Phase 2 Recruiting
250 enrolled
Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

NCT01822405 2013-04-02

ORT-OXI-2009

Hospital Universitario de Canarias

Phase 2 Unknown
42 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡